Com. v. Mulkin, O.

2020 Pa. Super. 30
Superior Court of Pennsylvania·Decided February 10, 2020·No. 740 WDA 2019·Published·Cited by 1 cases

Opinion

2020 PA Super 30

COMMONWEALTH OF PENNSYLVANIA : IN THE SUPERIOR COURT OF : PENNSYLVANIA

:

v. :

:

:

OAKLEY ZEDDY MULKIN :

:

Appellant : No. 740 WDA 2019

Appeal from the Judgment of Sentence Entered April 10, 2019 In the Court of Common Pleas of Potter County Criminal Division at No(s): CP-53-CR-0000142-2018

BEFORE: GANTMAN, P.J.E., LAZARUS, J., and PELLEGRINI, J.* OPINION BY LAZARUS, J.: FILED FEBRUARY 10, 2020 Oakley Zeddy Mulkin appeals from the judgment of sentence, entered in the Court of Common Pleas of Potter County, following his conviction for delivery of a designer drug,1 delivery of a non-controlled substance,2 criminal use of a communication facility,3 and involuntary manslaughter.4 After careful review, we vacate the judgment of sentence and remand for resentencing.

* Retired Senior Judge assigned to the Superior Court. 1 35 P.S. § 780-113(a)(36). 2 35 P.S. § 780-113(a)(35). 3 18 Pa.C.S.A. § 7512(a). 4 18 Pa.C.S.A. § 2504(a).

On May 11, 2016, Mulkin sold furanylfentanyl5 to a friend, Jordan Whitesell, who overdosed on the drug hours later. Following a three-day jury trial, Mulkin was found guilty of the above-mentioned crimes on April 3, 2019. On April 10, 2019, after considering a pre-sentence investigation (PSI) report, the trial court sentenced Mulkin to 18-36 months’ imprisonment for involuntary manslaughter, an aggravated-range sentence,6 and imposed standard-range sentences of 9-18 months’ imprisonment for delivery of a designer drug7 and 9-18 months’ imprisonment for criminal use of a communication facility. The trial court stated on the record that an aggravated-range sentence on the involuntary manslaughter count was justified because Mulkin delivered drugs he knew to have recently caused others to overdose,8 and because Mulkin had previously been caught with

controlled substances while incarcerated for drug possession.

5Furanylfentanyl is a derivative of the synthetic opioid, Fentanyl. N.T. Trial, 6/20/19, at 200-23. Fentanyl is 80 to 100 times more potent than morphine, and furanylfentanyl is slightly less potent than Fentanyl. Id.

6 With an offense gravity score (OGS) of 6 for involuntary manslaughter and Mulkin’s prior record score (PRS) of 0, the standard-range minimum sentence at that count was 3-12 months’ imprisonment, and the aggravated range minimum was 18 months’ imprisonment. See 204 Pa.Code § 303.16(a).

7 For sentencing purposes, Mulkin’s conviction for delivery of a controlled substance merged delivery of a designer drug.

8 In May of 2016, Mulkin purchased several baggies of furanylfentanyl, which he thought contained heroin, for himself and Whitesell. N.T. Trial, 4/1/19 at 121-22. At the time of purchase, Mulkin was told that other drug users had recently overdosed after ingesting that particular batch of drugs. Id. at 121.

On April 18, 2019, Mulkin filed a timely motion to modify sentence which the trial court denied on May 2, 2019. On May 11, 2019, Mulkin filed a timely notice of appeal followed by a court-ordered Pa.R.A.P. 1925(b) concise statement of errors complained of on appeal. He presents the following issue for our consideration: “Did the [s]entencing [c]ourt abuse [its] discretion by relying on inappropriate factors and by ignoring mitigating evidence when it aggravated [Mulkin’s] sentence beyond the standard range?” Brief for Appellant, at 5.

Mulkin’s claim represents a challenge to the discretionary aspects of his sentence. Commonwealth v. Prestidge, 539 A.2d 439, 441 (Pa. Super. 1988). An appeal raising the discretionary aspects of sentencing is not guaranteed as of right; rather, it is considered a petition for permission to appeal. Commonwealth v. Williams, 562 A.2d 1385, 1386-87 (Pa. Super. 1989) (en banc). In order to reach the merits of a discretionary aspects claim, we must engage in a four-part analysis to determine:

(1) whether appellant has filed a timely notice of appeal, see Pa.R.A.P. 902 and 903; (2) whether the issue was properly preserved at sentencing or in a motion to reconsider and modify sentence, see Pa.R.Crim.P. [720]; (3) whether appellant’s brief has a fatal defect, Pa.R.A.P. 2119(f); and (4) whether there is a substantial question that the sentence appealed from is not appropriate under the Sentencing Code.

***

Accordingly, Mulkin advised Whitesell upon delivering the drugs not to inject them intravenously “because [he] was told that it was a potent batch of heroin.” Id. at 124.

The determination of what constitutes a substantial question must be evaluated on a case-by-case basis. A substantial question exists only when the appellant advances a colorable argument that the sentencing judge’s actions were either: (1) inconsistent with a specific provision of the Sentencing Code; or (2) contrary to the fundamental norms which underlie the sentencing process.

Commonwealth v. Griffin, 65 A.3d 932, 935-36 (Pa. Super. 2013) (citations and quotations omitted).

Here, Mulkin filed a post-sentence motion to modify his sentence, a timely notice of appeal, and included in his brief a concise statement of reasons relied upon for appeal pursuant to Rule 2119(f). Additionally, Mulkin raises a substantial question by asserting the sentencing court relied on an impermissible factor and ignored mitigating evidence when imposing an aggravated-range sentence for involuntary manslaughter. See Commonwealth v. Roden, 730 A.2d 995 (Pa. Super. 1999) (sentencing court relying on impermissible factor raises substantial question); see also Commonwealth v. Felmlee, 828 A.2d 1105, 1107 (Pa. Super. 2003) (imposition of aggravated-range sentence without considering mitigating factors raises substantial question).

We, therefore, address Mulkin’s claim, which raises two arguments:

first, that the court erred by relying on an impermissible factor, and second, that the court erred by ignoring mitigating evidence.9

9 Mulkin contends that the court failed to consider, inter alia, (1) positive character references from his mother, former employer, and lifelong family friend; (2) that he graduated from high school; (3) his strong work ethic; (4) his sincere remorse; and (5) that his criminal history is limited to non-violent drug offenses. See Brief of Appellant, at 14-17.

We note that when imposing sentence, the trial court is granted broad discretion, as it is in the best position to determine the proper penalty for a particular offense based upon an evaluation of the individual circumstances before it. Commonwealth v. Walls, 926 A.2d 957, 961 (Pa. 2017). We are also cognizant of the fact that the trial court considered a PSI before imposing Mulkin’s sentence. Commonwealth v. Ventura, 975 A.2d 1128, 1135 (Pa. Super. 2009) (sentencing court informed by PSI presumed aware of relevant factors).

Mulkin’s first argument is waived, as he fails to reference any legal authority for the proposition that the sentencing court abused its discretion by impermissibly relying on his drug-related prison infraction while incarcerated on unrelated drug possession charges as a reason to aggravate his sentence. Brief of Appellant, at 13; see Pa.R.A.P. 2119(b) (party must direct court’s attention to specific authority relied upon); Commonwealth v. Johnson, 985 A.2d 915, 924 (Pa. 2009) (“[W]here an appellate brief fails to provide any discussion of a claim with citation to relevant authority or fails to develop the issue in any meaningful fashion capable of review, that claim is waived.”). We, therefore, consider only the portion of Mulkin’s claim relating to the sentencing court’s alleged failure to “consider the mitigating evidence presented at the sentencing hearing.” Brief of Appellant, at 12.

Free access — add to your briefcase to read the full text and ask questions with AI

Com. v. Mulkin, O., 2020 Pa. Super. 30 (Pa. Ct. App. 2020).

2020 Pa. Super. 30 (Com. v. Mulkin, O.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Com. v. Mulkin, O.
2020 Pa. Super. 30 (Superior Court of Pennsylvania, 2020)